U-Chart Analysis:Nippon Shinyaku Co.,Ltd.:4516

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Nippon Shinyaku Co.,Ltd. Go to web site 4516 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Nippon Shinyaku Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nippon Shinyaku Co.,Ltd. Balance Sheet 2023年3月期 Nippon Shinyaku Co.,Ltd. Balance Sheet 2022年3月期 Nippon Shinyaku Co.,Ltd. Balance Sheet 2021年3月期 Nippon Shinyaku Co.,Ltd. Balance Sheet 2020年3月期 Nippon Shinyaku Co.,Ltd. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents 60,047 60,566 47,770 36,005 31,519
Other Current AssetsHelp 97,826 89,158 91,285 85,920 79,201
Tangible Fixed AssetsHelp 34,994 31,057 29,396 20,944 20,575
Intangible Fixed AssetHelp 17,155 14,050 9,833 546 412
Investments and OthersHelp 27,429 25,112 27,162 31,602 37,056
Total AssetsHelp 237,451 219,943 205,446 175,017 168,763
Total Current LiabilitiesHelp 40,677 38,138 42,283 29,526 33,826
Total Long-term LiabilitiesHelp 1,148 1,219 2 0 0
Shareholder's EquityHelp 195,626 180,586 163,161 145,491 134,937
Total LiabilitiesHelp 237,451 219,943 205,446 175,017 168,763

Nippon Shinyaku Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nippon Shinyaku Co.,Ltd. Profit and Loss Account 2023年3月期 Nippon Shinyaku Co.,Ltd. Profit and Loss Account 2022年3月期 Nippon Shinyaku Co.,Ltd. Profit and Loss Account 2021年3月期 Nippon Shinyaku Co.,Ltd. Profit and Loss Account 2020年3月期 Nippon Shinyaku Co.,Ltd. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales 144,175 137,547 121,885 116,637 114,716
Total Sales 144,175 137,547 121,885 116,637 114,716
Cost of SalesHelp 55,980 50,191 49,306 53,155 50,952
Other Costs and RevenueHelp 65,382 62,370 53,038 46,615 47,461
Total CostsHelp 121,362 112,561 102,344 99,770 98,413
Net RevenueHelp 88,195 87,356 72,579 63,482 63,764
Earnings Before TaxHelp 30,489 33,301 27,608 22,442 21,540
Net IncomeHelp 22,813 24,986 19,541 16,867 16,303
Net Income 22,813 24,986 19,541 16,867 16,303

Nippon Shinyaku Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Nippon Shinyaku Co.,Ltd. Cash Flow Statement 2023年3月期 Nippon Shinyaku Co.,Ltd. Cash Flow Statement 2022年3月期 Nippon Shinyaku Co.,Ltd. Cash Flow Statement 2021年3月期 Nippon Shinyaku Co.,Ltd. Cash Flow Statement 2020年3月期 Nippon Shinyaku Co.,Ltd. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help 26,171 21,315 23,664 12,736 15,310
Investing Cash Flow(ICF)Help -17,631 -10,037 -1,658 -2,339 511
Financing Cash FlowHelp -9,605 -8,407 -7,667 -5,660 -3,708
Exchange Difference of Cash and Cash EquivalentsHelp 547 -188 -40 -72 9
Net Increase and Decrease in Cash and Cash Equivalentsn -518 2,683 14,299 4,665 12,122

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Nippon Shinyaku Co.,Ltd.

Company where related level is highHelp

Chiome Bioscience Inc.
Cyfuse Biomedical K.K.
BIOFERMIN PHARMACEUTICAL CO.,LTD.
SAWAI GROUP HOLDINGS Co., Ltd.
SEIKAGAKU CORPORATION
Noile-Immune Biotech Inc.
Solasia Pharma K.K.
Fuso Pharmaceutical Industries, Ltd.
Toyama Chemical Co.,Ltd.
HEALIOS K.K.